Texas Tech University Health Sciences Center Recognized as Fierce Innovation Awards: Healthcare Edition Program Finalist

Texas Tech University Health Sciences Center’s (TTUHSC) InfantRisk Center recently announced it was selected as a finalist in this year’s Fierce Innovation Awards: Healthcare Edition, an awards program from the publisher of FierceHealthIT, FierceHealthcare and FierceMobileHealthcare. TTUHSC was recognized as a finalist in the category of Health Information Exchange for its innovative, industry leading product, MommyMeds.

MommyMeds is a smartphone application that gives users 24/7 access reliable safety ratings and other information on more than 20,000 drugs, syndromes and other products. The app is based on the bestselling book, “Medications and Mothers’ Milk” written by Thomas Hale, R.Ph., Ph.D., professor of pediatrics at TTUHSC and one of the world’s leading expert in perinatal pharmacology.

TTUHSC President Tedd L. Mitchell, M.D., said university leaders are delighted that the InfantRisk Center, under Hale’s leadership, is a finalist for this prestigious award.

“Medications can have long-lasting effects for mothers and their children,” Mitchell said.
“We are proud of Dr. Hale’s contributions to transformative and innovative ways to assist mothers during and after pregnancy.”

Finalists were selected by a distinguished panel of CIOs and other executives from renowned U.S. hospitals and health care systems, including the Mayo Clinic, Boston Children’s Hospital, Memorial Sloan-Kettering Cancer Center, University of Michigan Hospitals and Health Centers and Beth Israel Deaconess Medical Center.

“These finalists are a cross-section of game-changing solutions providers who are helping providers to transform healthcare delivery and improve care,” said Wendy Johnson, FierceMarkets’ health care group publisher. “This is truly an exciting time in health care. Disruptive changes are happening that will lead to lasting improvements and millions of saved — and improved — lives.”

All applications were evaluated based on the following criteria: impact on quality of care and patient outcomes; impact on care efficiency; impact on health care information exchange; technology Innovation; financial Impact; market validation; compatibility with existing health IT systems; end-user experience and overall level of innovation. Finalists were selected based on the judges’ scores in each area.

MommyMeds will soon be available to consumers, and includes search capabilities that allow users to enter product name and/or sort by category to obtain product safety information about appropriate drugs for various conditions during pregnancy or breastfeeding (headache, nausea, allergies, etc.) and indicate if that product is safe or hazardous. The app also allows users to scan a barcode of an over-the-counter drug to obtain product safety information.

The InfantRisk Center is dedicated to providing up-to-date evidence-based information on the use of medications during pregnancy and breastfeeding.  The goal of the center’s staff and website is to provide accurate information regarding the risks of exposure to mothers and their babies. By educating health care professionals and the general public alike, the InfantRisk Center aims to reduce the number of birth defects as well as create healthy breastfeeding relationships.

About FierceMarkets


FierceMarkets, a wholly owned subsidiary of Questex Media Group, is a leader in B2B emedia, providing information and marketing services in the telecommunications, life sciences, healthcare, IT, energy, government, finance, and retail industries through its portfolio of email newsletters, websites, webinars and live events. Every business day, FierceMarkets' wide array of publications reaches more than 1.3 million executives in more than 100 countries.

For more breaking news and experts, follow @ttuhscnews on Twitter.